ATE269108T1 - Behandlung von protein enthaltenden flüssigkeiten - Google Patents

Behandlung von protein enthaltenden flüssigkeiten

Info

Publication number
ATE269108T1
ATE269108T1 AT00903788T AT00903788T ATE269108T1 AT E269108 T1 ATE269108 T1 AT E269108T1 AT 00903788 T AT00903788 T AT 00903788T AT 00903788 T AT00903788 T AT 00903788T AT E269108 T1 ATE269108 T1 AT E269108T1
Authority
AT
Austria
Prior art keywords
liquids containing
treatment
containing protein
cationic
microns
Prior art date
Application number
AT00903788T
Other languages
English (en)
Inventor
Peter Reynolds Foster
Anne Gillian Welch
Original Assignee
Common Services Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE269108(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9901139.7A external-priority patent/GB9901139D0/en
Priority claimed from GBGB9910476.2A external-priority patent/GB9910476D0/en
Application filed by Common Services Agency filed Critical Common Services Agency
Application granted granted Critical
Publication of ATE269108T1 publication Critical patent/ATE269108T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022Filtration

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00903788T 1999-01-19 2000-01-19 Behandlung von protein enthaltenden flüssigkeiten ATE269108T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9901139.7A GB9901139D0 (en) 1999-01-19 1999-01-19 Treatment of protein-containing liquids
GBGB9910476.2A GB9910476D0 (en) 1999-05-07 1999-05-07 Treating protein-containing liquids
PCT/GB2000/000123 WO2000043048A1 (en) 1999-01-19 2000-01-19 Treating protein-containing liquids

Publications (1)

Publication Number Publication Date
ATE269108T1 true ATE269108T1 (de) 2004-07-15

Family

ID=26315000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903788T ATE269108T1 (de) 1999-01-19 2000-01-19 Behandlung von protein enthaltenden flüssigkeiten

Country Status (11)

Country Link
US (1) US8226776B1 (de)
EP (1) EP1144015B2 (de)
JP (1) JP4524045B2 (de)
AT (1) ATE269108T1 (de)
AU (1) AU774996B2 (de)
CA (1) CA2359932C (de)
DE (1) DE60011567T3 (de)
DK (1) DK1144015T4 (de)
ES (1) ES2218118T5 (de)
PT (1) PT1144015E (de)
WO (1) WO2000043048A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8226776B1 (en) 1999-01-19 2012-07-24 Bio Products Laboratory Limited Treating protein-containing liquids
US6602410B1 (en) 2000-11-14 2003-08-05 The Procter & Gamble Comapny Water purifying kits
AU784808B2 (en) * 2001-04-02 2006-06-29 Kedrion Melville Inc. Prion and viral clearance process
CN100507567C (zh) 2002-05-23 2009-07-01 奥索临床诊断有限公司 朊病毒蛋白的去除
JP2006182649A (ja) * 2003-04-09 2006-07-13 Chemo Sero Therapeut Res Inst アルブミン凝集体及び/または不純蛋白質の除去方法
AU2005229674B2 (en) 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
EP1941051A1 (de) * 2005-10-28 2008-07-09 Alicon AG Verfahren zur konzentration, aufreinigung und abtrennung von prionprotein
EP2027875A1 (de) * 2007-08-23 2009-02-25 Octapharma AG Verfahren zur Isolierung und Reinigung eines prionenproteinfreien Target-Proteins
GB2578880A (en) 2018-11-09 2020-06-03 For Spills Ltd Method and composition
GB2579252A (en) 2018-11-28 2020-06-17 For Spills Ltd Biocidal formulation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309247A (en) 1976-03-15 1982-01-05 Amf Incorporated Filter and method of making same
GB2043734B (en) * 1979-03-01 1983-08-17 Amf Inc Filter and method of making same
GB2045828B (en) * 1979-04-06 1983-08-24 Amf Inc Filter and method of making same
US4278551A (en) 1979-07-30 1981-07-14 Amf Incorporated Wound cartridge filters
US4288462A (en) 1980-02-04 1981-09-08 Amf Incorporated Method for removing cationic contaminants from beverages
IL59339A (en) * 1980-02-08 1982-09-30 Res Prod Rehovot Ltd Method for the performance of enzymatic reactions and reactors therefor
DE4343226A1 (de) 1993-12-17 1995-06-22 Schenk Filterbau Gmbh Tiefenfilter zur Abtötung von Mikroorganismen und Inaktivierung von Viren und dessen Anwendung
EP0679405A1 (de) 1994-04-25 1995-11-02 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Abtrennung von Viren aus Proteinlösungen
DE4429558A1 (de) * 1994-08-19 1996-02-22 Sanorell Pharma Gmbh & Co Verfahren zur Herstellung von infektionsfreien pharmazeutischen Präparaten und/oder Nahrungsmitteln aus infektiösem Material
ATE327774T1 (de) * 1996-03-21 2006-06-15 Bayer Corp Verwendung von strukturierten tiefenfiltern zur entfernung von viren
DK0937735T3 (da) 1998-02-11 2003-06-02 Zlb Bioplasma Ag Fremgangsmåde til fjernelse af kausalt agens/kausale agentia for overførbare spongiforme encephalopatier fra proteinopløsninger
US8226776B1 (en) 1999-01-19 2012-07-24 Bio Products Laboratory Limited Treating protein-containing liquids

Also Published As

Publication number Publication date
US8226776B1 (en) 2012-07-24
AU2555300A (en) 2000-08-07
DE60011567T3 (de) 2011-06-09
DE60011567T2 (de) 2005-08-25
DK1144015T3 (da) 2004-10-18
EP1144015B2 (de) 2010-11-17
EP1144015A1 (de) 2001-10-17
DE60011567D1 (de) 2004-07-22
CA2359932A1 (en) 2000-07-27
JP2002535292A (ja) 2002-10-22
EP1144015B1 (de) 2004-06-16
DK1144015T4 (da) 2011-03-07
ES2218118T3 (es) 2004-11-16
CA2359932C (en) 2007-09-11
JP4524045B2 (ja) 2010-08-11
WO2000043048A1 (en) 2000-07-27
PT1144015E (pt) 2004-09-30
ES2218118T5 (es) 2011-04-06
AU774996B2 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
DE3788984D1 (de) Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom.
DE69106827D1 (de) Verfahren zur Herstellung von Mikrokapseln und Gegenstände, welche eingekapseltes Material enthalten.
DE69033509D1 (de) Laserverfahren zur Behandlung von Mikrokapseln oder Teilchen
DE69722635D1 (de) Behandlung von materialien zur verbesserung der behandlung von viskoelastische flüssigkeiten
ATE108668T1 (de) Transdermale applikation von 2-amino-6-n- propylamino-4,5,6,7-tetrahydrobenzothiazol.
DE69417510D1 (de) Verfahren zur Herstellung von feinteiligen, dichtpackenden und kugelförmigen Silberpartikeln
ATE438397T1 (de) Pharmazeutische zubereitung enthaltend pioglitazone und glimepiride zur verwendung in der behandlung von diabetes
ATE269108T1 (de) Behandlung von protein enthaltenden flüssigkeiten
DE69732225D1 (de) Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür
DE69735974D1 (de) Verwendung von strukturierten Tiefenfiltern zur Entfernung von Viren
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
EP0733122A4 (de) Fusionsproteine, die das rep-protein des adeno-assoziierten virus enthalten, und proteine aus bakterien
DE69011951D1 (de) Verfahren zur Behandlung und Herstellung von Material.
DE59406150D1 (de) Tiefenfilter zur abtötung von mikroorganismen und inaktivierung von viren und dessen anwendung
ATE428495T1 (de) Stoffe zur enternung von cannabinoiden und säulen mit diesen stoffen zur entfernung von cannabinoiden
MA21419A1 (fr) Traitement de gateaux de filtration impregnes de matiere toxique.
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
ATE421339T1 (de) Vereinfachte methode zur entfernung von freiem protein während der herstellung von protein- polysaccharid-konjugaten und impfstoffen unter verwendung von medien mit limitierter durchlässigkeit
AU7379687A (en) A process for obtaining active proteins from a biologically inactive form
FR2646360B1 (fr) Systeme de filtrage de liquides contenant des particules en suspension
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ES2047043T3 (es) Procedimiento de purificacion.
DE60045894D1 (de) Extraktion von polysaccharide aus algenprotein und verwendung davon
DE69837148D1 (de) Chimäre proteine zur behandlung von diabetes
DE68922813D1 (de) System und Verfahren zur Zentrifugalbehandlung grosser Volumina von Suspensionszellkulturen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1144015

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1144015

Country of ref document: EP